ArticleOrthopaedic surgery2026
A New Stage and Classification of Osteonecrosis of the Femoral Head Based on MRI With Pathophysiological Interpretation.
Article in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundTo explore the influence of the new stage and classification system based on the correlation between MRI and pathological features on the collapse, symptoms, and function of femoral head necrosis. Existing radiographic staging systems primarily evaluate structural changes and lesion morphology but provide limited information regarding intraosseous biological activity and pathological heterogeneity. Clinically, patients within the same ARCO stage often demonstrate markedly different symptoms, collapse patterns, and treatment responses, highlighting the need for an MRI-based classification reflecting underlying pathological status.
methodsThis retrospective study included 100 patients (200 hips) who were diagnosed with bilateral ONFH. According to the degree of fibrosis in the necrotic area in a mid-coronal section on hip MRI, the MRI stage of ONFH can be divided into three types. F1, borderline fibrosis (banded low signal); F2, partial fibrosis in the necrotic area (partial low signal); F3, global fibrosis in the necrotic area (global low signal). Based on the level of inflammatory response, the MRI classification of ONFH can be divided into four. E0, pathological stable type (no bone marrow edema and inflammatory); E1, partial edema of the femoral head and neck; E2, global edema of the femoral head and neck; E3, extensive edema of the proximal femur. The radiological evaluations were based on plain X-rays and MRI.
resultsThere was a significant difference in the collapse rate between F1 (7.1%), F2 (66.3%), and F3 (92.1%) (p < 0.001). The collapse rate in E0 (11.1%), E1 (66.7%), E2 (85.3%), and E3 (77.8%) was significantly different (p < 0.001). There was also a significant difference in pain level and hip function between MRI stage and classification (p < 0.001). The later the stage, the higher the pain level, and similar results in hip functions. With the aggravation of bone marrow edema, the patient's pain level increases and hip function decreases. ROC analysis demonstrated that MRI stage based on fibrosis showed the highest discriminative ability for femoral head collapse (AUC = 0.819), compared with ARCO stage (AUC = 0.756) and MRI classification based on inflammatory response (AUC = 0.714). However, given the cross-sectional design and the potential for incorporation bias, these findings should be interpreted with caution.
conclusionMRI-based assessment of fibrosis extent and inflammatory activity provides additional information on intraosseous pathological status that is not captured by conventional radiographic stage systems and is significantly associated with femoral head collapse, pain, and hip function. This classification may have potential value for disease stratification and clinical assessment. However, its role in guiding treatment decisions and predicting longitudinal outcomes requires further validation in prospective studies. LEVEL OF EVIDENCE: 3:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.